University of Ulm

Ulm 89081

1 studies enrolling now · 11 studies all time

What they study most

Acute Lymphoblastic Leukemia (ALL), Amyotrophic Lateral Sclerosis, Bone Marrow Transplantation, Diabetes, Frontotemporal Dementia, Genetic Obesity, Malignant Melanoma, Motor Neuron Disease, Myocardial Infarction, Obesity, Obesity Associated With Defects in Leptin-melanocortin Pathway, Obesity Due to Melanocortin 4 Receptor Deficiency

Studies at this site

• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS — Recruiting now
• Hemofiltration for Respiratory Failure After Bone Marrow Transplantation — Completed
• A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2) — Completed
• Long Term Extension Trial of Setmelanotide — Completed
• MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity — Completed
• Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia — Completed
• Insulin Resistance Intervention After Stroke Trial — Completed
• Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) — Completed
• Vaccine Therapy for Patients With Stage III Melanoma — Status unconfirmed
• Vaccine Therapy for Patients With Stage IV Melanoma — Status unconfirmed